Table 2.
Oxcarbazepine (OXC, 120 μmol/L) modulated the biophysical properties of mutant and WT channels.
| Activation | Steady inactivation | Fast inactivation | Recovery from fast inactivation | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| V1/2 (mV) | K | n | V1/2 (mV) | K | n | V1/2 (mV) | K | n | τ (ms) | n | |
| WT | − 19.5 ± 0.7 | 3.3 ± 0.1 | 8 | − 66.3 ± 0.6 | 5.6 ± 0.3 | 9 | − 38.0 ± 0.4 | 8.5 ± 0.3 | 7 | 1.7 ± 0.3 | 12 |
| WT + OXC | − 23.6 ± 1.2** | 3.7 ± 0.2 | 8 | − 71.7 ± 1.5** | 5.8 ± 0.2 | 9 | − 46.1 ± 1.5*** | 8.8 ± 0.5 | 7 | 2.5 ± 0.2** | 17 |
| N641Y | − 17.0 ± 0.8 | 3.6 ± 0.4 | 6 | − 62.7 ± 1.1 | 6.5 ± 0.1 | 14 | − 37.1 ± 0.9 | 5.5 ± 0.3 | 9 | 1.3 ± 0.1 | 8 |
| N641Y + OXC | − 24.6 ± 0.6*** | 3.7 ± 0.2 | 6 | − 69.1 ± 1.4** | 6.7 ± 0.4 | 14 | − 46.4 ± 2.1*** | 4.9 ± 0.8 | 9 | 2.8 ± 0.3*** | 8 |
| K655R | − 17.8 ± 1.8 | 3.5 ± 0.3 | 9 | − 67.9 ± 0.3 | 5.1 ± 0.2 | 11 | − 37.0 ± 0.9 | 8.1 ± 0.5 | 13 | 1.4 ± 0.1 | 17 |
| K655R + OXC | − 24.3 ± 0.7* | 3.6 ± 0.4 | 12 | − 71.3 ± 0.7*** | 6.1 ± 0.2** | 11 | − 41.5 ± 1.2** | 8.5 ± 0.5 | 13 | 1.8 ± 0.1** | 16 |
| W1150R | − 23.7 ± 1.9 | 2.8 ± 0.3 | 12 | − 64.5 ± 0.5 | 5.6 ± 0.2 | 10 | − 37.5 ± 1.3 | 8.9 ± 1.3 | 9 | 2.4 ± 0.2 | 11 |
| W1150R + OXC | − 31.2 ± 2.5* | 2.9 ± 0.4 | 12 | − 73.1 ± 2.0*** | 6.1 ± 0.3 | 10 | − 50.3 ± 2.3*** | 8.9 ± 1.0 | 9 | 3.2 ± 0.3* | 11 |
V1/2, voltage midpoint activation or inactivation; K, slope factor; n, number of cells; τ, time constant.
Values represent the mean ± SEM.
*P < 0.05, **P < 0.01, ***P < 0.001, unpaired Student’s t-test.